| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Robotic Surgical Procedures | 75 | 2025 | 367 | 29.170 |
Why?
|
| Endoscopy | 50 | 2025 | 374 | 16.270 |
Why?
|
| Coronary Artery Bypass | 49 | 2025 | 252 | 13.690 |
Why?
|
| Coronary Artery Disease | 32 | 2025 | 395 | 12.490 |
Why?
|
| Cardiac Surgical Procedures | 27 | 2025 | 519 | 9.190 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 18 | 2024 | 42 | 8.130 |
Why?
|
| Heart Valve Prosthesis Implantation | 13 | 2025 | 199 | 5.720 |
Why?
|
| Robotics | 14 | 2022 | 273 | 4.700 |
Why?
|
| Mammary Arteries | 13 | 2024 | 34 | 4.630 |
Why?
|
| Percutaneous Coronary Intervention | 7 | 2025 | 76 | 4.390 |
Why?
|
| Mitral Valve | 14 | 2025 | 280 | 4.260 |
Why?
|
| Mitral Valve Insufficiency | 10 | 2025 | 210 | 4.250 |
Why?
|
| Aortic Valve | 11 | 2025 | 277 | 4.230 |
Why?
|
| Minimally Invasive Surgical Procedures | 22 | 2024 | 287 | 3.470 |
Why?
|
| Coronary Vessels | 9 | 2024 | 200 | 3.340 |
Why?
|
| Treatment Outcome | 48 | 2025 | 9228 | 2.890 |
Why?
|
| Retrospective Studies | 38 | 2025 | 10307 | 2.100 |
Why?
|
| Humans | 121 | 2025 | 95992 | 1.960 |
Why?
|
| Atrial Fibrillation | 6 | 2024 | 444 | 1.810 |
Why?
|
| Aged | 47 | 2025 | 20927 | 1.790 |
Why?
|
| Aortic Valve Stenosis | 5 | 2024 | 169 | 1.650 |
Why?
|
| Vascular Patency | 9 | 2023 | 127 | 1.590 |
Why?
|
| Anastomosis, Surgical | 8 | 2024 | 284 | 1.550 |
Why?
|
| Middle Aged | 48 | 2025 | 28299 | 1.530 |
Why?
|
| Heart Valve Diseases | 6 | 2025 | 122 | 1.520 |
Why?
|
| Male | 59 | 2025 | 45792 | 1.490 |
Why?
|
| Coronary Angiography | 10 | 2024 | 262 | 1.430 |
Why?
|
| Tricuspid Valve Insufficiency | 2 | 2025 | 130 | 1.350 |
Why?
|
| Female | 52 | 2025 | 49980 | 1.300 |
Why?
|
| Aorta | 3 | 2023 | 294 | 1.290 |
Why?
|
| Heart Neoplasms | 3 | 2019 | 65 | 1.270 |
Why?
|
| Tricuspid Valve | 3 | 2025 | 113 | 1.140 |
Why?
|
| Myocardial Bridging | 2 | 2024 | 5 | 1.030 |
Why?
|
| Pericardiectomy | 4 | 2020 | 9 | 1.030 |
Why?
|
| Length of Stay | 11 | 2025 | 835 | 1.020 |
Why?
|
| Bioprosthesis | 2 | 2024 | 43 | 1.000 |
Why?
|
| Operative Time | 6 | 2025 | 168 | 0.970 |
Why?
|
| Surgeons | 4 | 2025 | 298 | 0.920 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2023 | 50 | 0.920 |
Why?
|
| Obesity, Morbid | 2 | 2018 | 248 | 0.880 |
Why?
|
| beta-Lactam Resistance | 2 | 2016 | 12 | 0.860 |
Why?
|
| Carbapenems | 2 | 2016 | 12 | 0.860 |
Why?
|
| Myocardial Revascularization | 3 | 2021 | 32 | 0.860 |
Why?
|
| Acinetobacter Infections | 2 | 2016 | 19 | 0.850 |
Why?
|
| Cryosurgery | 1 | 2024 | 68 | 0.840 |
Why?
|
| Thoracic Wall | 1 | 2024 | 27 | 0.830 |
Why?
|
| Myocardial Infarction | 3 | 2023 | 436 | 0.830 |
Why?
|
| Iliac Artery | 1 | 2024 | 42 | 0.830 |
Why?
|
| Follow-Up Studies | 9 | 2024 | 3922 | 0.810 |
Why?
|
| Thoracic Surgery | 2 | 2021 | 62 | 0.800 |
Why?
|
| Aged, 80 and over | 17 | 2025 | 7224 | 0.780 |
Why?
|
| Balloon Occlusion | 1 | 2023 | 33 | 0.770 |
Why?
|
| Patient Reported Outcome Measures | 4 | 2025 | 286 | 0.760 |
Why?
|
| Heart Valve Prosthesis | 4 | 2025 | 107 | 0.740 |
Why?
|
| Fibroma | 2 | 2019 | 33 | 0.730 |
Why?
|
| Ischemic Attack, Transient | 1 | 2023 | 188 | 0.710 |
Why?
|
| One-Lung Ventilation | 2 | 2020 | 4 | 0.700 |
Why?
|
| Pulmonary Veins | 2 | 2020 | 111 | 0.690 |
Why?
|
| Cardiopulmonary Bypass | 5 | 2024 | 162 | 0.690 |
Why?
|
| Reoperation | 3 | 2019 | 712 | 0.690 |
Why?
|
| Scimitar Syndrome | 1 | 2020 | 3 | 0.660 |
Why?
|
| Datasets as Topic | 3 | 2025 | 81 | 0.650 |
Why?
|
| Cross Infection | 2 | 2012 | 159 | 0.650 |
Why?
|
| Vena Cava, Superior | 1 | 2020 | 58 | 0.640 |
Why?
|
| Anti-Bacterial Agents | 3 | 2016 | 848 | 0.630 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2020 | 72 | 0.630 |
Why?
|
| Mortality | 2 | 2018 | 156 | 0.620 |
Why?
|
| Analgesia | 2 | 2021 | 64 | 0.610 |
Why?
|
| Pericarditis | 1 | 2019 | 17 | 0.610 |
Why?
|
| Sutureless Surgical Procedures | 1 | 2019 | 5 | 0.600 |
Why?
|
| Physician Assistants | 1 | 2019 | 27 | 0.590 |
Why?
|
| Mitral Valve Stenosis | 1 | 2019 | 38 | 0.590 |
Why?
|
| Angioplasty, Balloon | 1 | 2019 | 98 | 0.590 |
Why?
|
| Acute Kidney Injury | 1 | 2023 | 341 | 0.590 |
Why?
|
| Blood Loss, Surgical | 1 | 2019 | 133 | 0.570 |
Why?
|
| Blood Transfusion | 1 | 2019 | 180 | 0.550 |
Why?
|
| Tertiary Care Centers | 3 | 2016 | 129 | 0.550 |
Why?
|
| Postoperative Complications | 6 | 2024 | 2603 | 0.550 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2018 | 119 | 0.540 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2019 | 144 | 0.540 |
Why?
|
| Equipment Design | 6 | 2024 | 435 | 0.530 |
Why?
|
| Adult | 16 | 2024 | 28636 | 0.530 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2017 | 9 | 0.510 |
Why?
|
| Suture Techniques | 1 | 2018 | 143 | 0.510 |
Why?
|
| Risk Factors | 9 | 2024 | 5992 | 0.490 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2018 | 248 | 0.490 |
Why?
|
| Acinetobacter baumannii | 1 | 2016 | 29 | 0.490 |
Why?
|
| Heart Ventricles | 2 | 2019 | 826 | 0.490 |
Why?
|
| Stroke | 2 | 2023 | 1089 | 0.480 |
Why?
|
| Endovascular Procedures | 1 | 2020 | 334 | 0.480 |
Why?
|
| Hemorrhage | 1 | 2018 | 295 | 0.470 |
Why?
|
| beta-Lactamases | 1 | 2016 | 57 | 0.470 |
Why?
|
| Laparoscopy | 1 | 2022 | 784 | 0.460 |
Why?
|
| Bupivacaine | 1 | 2015 | 48 | 0.460 |
Why?
|
| Transcatheter Aortic Valve Replacement | 3 | 2022 | 74 | 0.460 |
Why?
|
| Anesthetics, Local | 1 | 2015 | 84 | 0.440 |
Why?
|
| Heart Diseases | 1 | 2017 | 318 | 0.440 |
Why?
|
| Feasibility Studies | 3 | 2024 | 819 | 0.430 |
Why?
|
| Catheter Ablation | 2 | 2016 | 365 | 0.430 |
Why?
|
| Pain Management | 1 | 2015 | 180 | 0.400 |
Why?
|
| Sternotomy | 2 | 2023 | 24 | 0.400 |
Why?
|
| Sternum | 2 | 2023 | 37 | 0.390 |
Why?
|
| Patient-Centered Care | 2 | 2025 | 229 | 0.380 |
Why?
|
| Heart Arrest, Induced | 2 | 2022 | 30 | 0.380 |
Why?
|
| Acinetobacter | 1 | 2012 | 4 | 0.370 |
Why?
|
| Klebsiella Infections | 1 | 2012 | 32 | 0.350 |
Why?
|
| Klebsiella pneumoniae | 1 | 2012 | 41 | 0.350 |
Why?
|
| Clinical Competence | 4 | 2025 | 858 | 0.350 |
Why?
|
| Disease Outbreaks | 1 | 2012 | 157 | 0.340 |
Why?
|
| Heart | 3 | 2023 | 596 | 0.320 |
Why?
|
| Coronary Disease | 1 | 2011 | 263 | 0.320 |
Why?
|
| Saudi Arabia | 3 | 2016 | 17 | 0.310 |
Why?
|
| Postoperative Period | 3 | 2019 | 318 | 0.300 |
Why?
|
| Perioperative Period | 2 | 2019 | 30 | 0.290 |
Why?
|
| Time Factors | 4 | 2024 | 5593 | 0.290 |
Why?
|
| Cardiac Resynchronization Therapy | 2 | 2020 | 89 | 0.290 |
Why?
|
| Heart Atria | 2 | 2016 | 297 | 0.280 |
Why?
|
| Ischemia | 2 | 2024 | 256 | 0.280 |
Why?
|
| Echocardiography | 3 | 2025 | 1010 | 0.280 |
Why?
|
| Hemodynamics | 3 | 2024 | 776 | 0.280 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2020 | 364 | 0.270 |
Why?
|
| Computed Tomography Angiography | 2 | 2020 | 166 | 0.270 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2018 | 62 | 0.270 |
Why?
|
| Heart Failure | 1 | 2018 | 1438 | 0.260 |
Why?
|
| Pericardium | 2 | 2019 | 84 | 0.260 |
Why?
|
| Prosthesis Design | 2 | 2019 | 311 | 0.260 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2020 | 233 | 0.260 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2017 | 700 | 0.260 |
Why?
|
| Stroke Volume | 2 | 2022 | 550 | 0.250 |
Why?
|
| Echocardiography, Three-Dimensional | 3 | 2017 | 528 | 0.250 |
Why?
|
| Ventricular Function, Left | 2 | 2022 | 677 | 0.240 |
Why?
|
| Drug-Eluting Stents | 1 | 2025 | 22 | 0.230 |
Why?
|
| Chordae Tendineae | 2 | 2015 | 23 | 0.230 |
Why?
|
| Heart Valves | 1 | 2025 | 26 | 0.220 |
Why?
|
| Combined Modality Therapy | 3 | 2018 | 1741 | 0.220 |
Why?
|
| Heart Transplantation | 2 | 2023 | 816 | 0.220 |
Why?
|
| Graft Occlusion, Vascular | 2 | 2019 | 100 | 0.210 |
Why?
|
| Analgesics, Opioid | 2 | 2021 | 514 | 0.210 |
Why?
|
| Endoscopes | 1 | 2004 | 10 | 0.210 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2016 | 153 | 0.210 |
Why?
|
| Surgical Stapling | 1 | 2004 | 17 | 0.210 |
Why?
|
| Microwaves | 1 | 2004 | 32 | 0.210 |
Why?
|
| Simulation Training | 2 | 2024 | 108 | 0.200 |
Why?
|
| Femoral Artery | 1 | 2024 | 91 | 0.200 |
Why?
|
| Catheterization, Peripheral | 1 | 2024 | 64 | 0.200 |
Why?
|
| Quality Indicators, Health Care | 1 | 2025 | 155 | 0.200 |
Why?
|
| Constriction | 1 | 2023 | 27 | 0.200 |
Why?
|
| Cluster Analysis | 2 | 2016 | 393 | 0.200 |
Why?
|
| Hospital Mortality | 2 | 2019 | 485 | 0.200 |
Why?
|
| Internship and Residency | 2 | 2023 | 1134 | 0.190 |
Why?
|
| Patient Positioning | 2 | 2020 | 65 | 0.190 |
Why?
|
| Catheterization | 1 | 2024 | 237 | 0.190 |
Why?
|
| Cardiovascular Diseases | 1 | 2009 | 778 | 0.190 |
Why?
|
| Thoracotomy | 1 | 2022 | 68 | 0.180 |
Why?
|
| Tissue and Organ Harvesting | 2 | 2024 | 83 | 0.180 |
Why?
|
| Prognosis | 2 | 2019 | 3993 | 0.170 |
Why?
|
| Research Design | 1 | 2025 | 630 | 0.170 |
Why?
|
| Survival Analysis | 2 | 2017 | 1541 | 0.170 |
Why?
|
| Colombia | 1 | 2020 | 18 | 0.170 |
Why?
|
| Pulmonary Edema | 1 | 2021 | 54 | 0.170 |
Why?
|
| Morphine | 1 | 2021 | 130 | 0.170 |
Why?
|
| Nobel Prize | 1 | 2020 | 10 | 0.160 |
Why?
|
| Lead Poisoning | 1 | 2020 | 13 | 0.160 |
Why?
|
| Mitral Valve Prolapse | 1 | 2020 | 24 | 0.160 |
Why?
|
| Prevalence | 3 | 2023 | 1355 | 0.160 |
Why?
|
| Congenital Abnormalities | 1 | 2020 | 67 | 0.160 |
Why?
|
| Patient Discharge | 1 | 2023 | 363 | 0.160 |
Why?
|
| Epicardial Mapping | 1 | 2019 | 12 | 0.150 |
Why?
|
| Career Choice | 1 | 2021 | 164 | 0.150 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2019 | 20 | 0.150 |
Why?
|
| Multidetector Computed Tomography | 1 | 2020 | 61 | 0.150 |
Why?
|
| Genotype | 2 | 2016 | 1883 | 0.150 |
Why?
|
| Pain | 1 | 2022 | 426 | 0.150 |
Why?
|
| Inservice Training | 1 | 2019 | 39 | 0.150 |
Why?
|
| History, 21st Century | 1 | 2020 | 192 | 0.150 |
Why?
|
| Coronary Occlusion | 1 | 2019 | 8 | 0.150 |
Why?
|
| Safety | 1 | 2019 | 147 | 0.150 |
Why?
|
| Young Adult | 3 | 2017 | 7034 | 0.150 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2019 | 67 | 0.140 |
Why?
|
| History, 20th Century | 1 | 2020 | 327 | 0.140 |
Why?
|
| Retreatment | 1 | 2018 | 107 | 0.140 |
Why?
|
| Medicare | 1 | 2022 | 458 | 0.140 |
Why?
|
| Interactive Ventilatory Support | 1 | 2018 | 5 | 0.140 |
Why?
|
| Surgical Staplers | 1 | 2018 | 10 | 0.140 |
Why?
|
| Vascular Calcification | 1 | 2019 | 54 | 0.140 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 218 | 0.130 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2017 | 16 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2019 | 348 | 0.130 |
Why?
|
| Gender Identity | 1 | 2018 | 60 | 0.130 |
Why?
|
| Saphenous Vein | 1 | 2017 | 61 | 0.130 |
Why?
|
| Radial Artery | 1 | 2017 | 37 | 0.130 |
Why?
|
| Morbidity | 1 | 2018 | 162 | 0.130 |
Why?
|
| Defibrillators, Implantable | 1 | 2019 | 190 | 0.130 |
Why?
|
| Renal Insufficiency | 1 | 2018 | 99 | 0.130 |
Why?
|
| Acute Disease | 1 | 2019 | 859 | 0.130 |
Why?
|
| Child, Preschool | 2 | 2016 | 3969 | 0.130 |
Why?
|
| Risk | 1 | 2018 | 666 | 0.130 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 2860 | 0.130 |
Why?
|
| Multilocus Sequence Typing | 1 | 2016 | 13 | 0.120 |
Why?
|
| Overweight | 1 | 2017 | 121 | 0.120 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 1982 | 0.120 |
Why?
|
| Atrial Septum | 1 | 2016 | 9 | 0.120 |
Why?
|
| Prospective Studies | 2 | 2018 | 4690 | 0.120 |
Why?
|
| Molecular Epidemiology | 1 | 2016 | 58 | 0.120 |
Why?
|
| Pericarditis, Constrictive | 1 | 2016 | 8 | 0.120 |
Why?
|
| Recurrence | 1 | 2019 | 1231 | 0.120 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 318 | 0.120 |
Why?
|
| Coronary Sinus | 1 | 2016 | 12 | 0.120 |
Why?
|
| Ventricular Fibrillation | 1 | 2016 | 78 | 0.120 |
Why?
|
| Plasmids | 1 | 2016 | 291 | 0.120 |
Why?
|
| Quality Improvement | 1 | 2020 | 502 | 0.120 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 31 | 0.120 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2016 | 119 | 0.120 |
Why?
|
| DNA, Bacterial | 1 | 2016 | 253 | 0.110 |
Why?
|
| Liposomes | 1 | 2015 | 101 | 0.110 |
Why?
|
| Hypertonic Solutions | 1 | 1995 | 17 | 0.110 |
Why?
|
| Heart Conduction System | 1 | 2016 | 140 | 0.110 |
Why?
|
| Organ Preservation Solutions | 1 | 1995 | 35 | 0.110 |
Why?
|
| Pacemaker, Artificial | 1 | 2016 | 116 | 0.110 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2015 | 73 | 0.110 |
Why?
|
| Therapeutics | 1 | 2014 | 13 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2017 | 2777 | 0.110 |
Why?
|
| Tachycardia, Ventricular | 1 | 2016 | 180 | 0.110 |
Why?
|
| Device Removal | 1 | 2016 | 169 | 0.110 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 115 | 0.110 |
Why?
|
| Body Mass Index | 1 | 2018 | 816 | 0.110 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 383 | 0.110 |
Why?
|
| Intraoperative Complications | 1 | 2016 | 197 | 0.110 |
Why?
|
| Delphi Technique | 2 | 2025 | 136 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 930 | 0.110 |
Why?
|
| Organ Preservation | 1 | 1995 | 130 | 0.100 |
Why?
|
| Comorbidity | 1 | 2017 | 1017 | 0.100 |
Why?
|
| Hypertension | 1 | 2019 | 775 | 0.100 |
Why?
|
| Coronary Stenosis | 1 | 2013 | 39 | 0.100 |
Why?
|
| Quality of Life | 1 | 2021 | 1816 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1962 | 0.100 |
Why?
|
| Pulmonary Artery | 1 | 1995 | 341 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 911 | 0.100 |
Why?
|
| Child | 2 | 2016 | 7621 | 0.100 |
Why?
|
| Software | 1 | 2017 | 698 | 0.100 |
Why?
|
| Heart Arrest | 1 | 2016 | 313 | 0.090 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2012 | 21 | 0.090 |
Why?
|
| Molecular Typing | 1 | 2012 | 19 | 0.090 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2012 | 52 | 0.090 |
Why?
|
| Wisconsin | 1 | 2011 | 46 | 0.090 |
Why?
|
| Adolescent | 2 | 2016 | 9878 | 0.090 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2012 | 117 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2012 | 3115 | 0.090 |
Why?
|
| Consensus | 2 | 2025 | 372 | 0.080 |
Why?
|
| Heart-Assist Devices | 1 | 2019 | 903 | 0.080 |
Why?
|
| Obesity | 1 | 2017 | 1029 | 0.080 |
Why?
|
| Reproducibility of Results | 4 | 2020 | 2885 | 0.080 |
Why?
|
| Electrocardiography | 3 | 2019 | 559 | 0.080 |
Why?
|
| Infection Control | 1 | 2012 | 132 | 0.080 |
Why?
|
| Algorithms | 2 | 2017 | 2018 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2012 | 721 | 0.080 |
Why?
|
| Burns | 1 | 2012 | 150 | 0.080 |
Why?
|
| Survival Rate | 2 | 2011 | 1978 | 0.080 |
Why?
|
| Angiography | 1 | 2009 | 209 | 0.070 |
Why?
|
| Image Enhancement | 3 | 2017 | 565 | 0.070 |
Why?
|
| Lung | 1 | 1995 | 1380 | 0.070 |
Why?
|
| Intensive Care Units | 1 | 2012 | 460 | 0.070 |
Why?
|
| Myocardial Ischemia | 1 | 2009 | 167 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2021 | 2498 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 2042 | 0.060 |
Why?
|
| Hospitalization | 1 | 2012 | 946 | 0.060 |
Why?
|
| Infant | 1 | 2012 | 3359 | 0.060 |
Why?
|
| Disease Progression | 1 | 2009 | 1561 | 0.050 |
Why?
|
| Models, Anatomic | 1 | 2024 | 93 | 0.050 |
Why?
|
| Cattle | 1 | 2024 | 401 | 0.050 |
Why?
|
| Equipment Failure Analysis | 1 | 2004 | 93 | 0.050 |
Why?
|
| Swine | 1 | 2024 | 607 | 0.050 |
Why?
|
| Ultrasonography, Interventional | 1 | 2023 | 126 | 0.050 |
Why?
|
| Demography | 1 | 2023 | 190 | 0.050 |
Why?
|
| Perioperative Care | 1 | 2024 | 188 | 0.050 |
Why?
|
| Risk Adjustment | 1 | 2022 | 40 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 2021 | 50 | 0.040 |
Why?
|
| Myocardial Contraction | 1 | 2003 | 253 | 0.040 |
Why?
|
| Decontamination | 1 | 2021 | 10 | 0.040 |
Why?
|
| Weights and Measures | 1 | 2020 | 7 | 0.040 |
Why?
|
| Contraindications | 1 | 2020 | 70 | 0.040 |
Why?
|
| Perception | 1 | 2021 | 185 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2023 | 542 | 0.040 |
Why?
|
| United States | 2 | 2023 | 7785 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 329 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 438 | 0.040 |
Why?
|
| Myocardium | 1 | 2022 | 606 | 0.040 |
Why?
|
| Animals | 3 | 2024 | 28901 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 2019 | 222 | 0.030 |
Why?
|
| Non-Randomized Controlled Trials as Topic | 1 | 2017 | 7 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1792 | 0.030 |
Why?
|
| Prosthesis Fitting | 1 | 2017 | 18 | 0.030 |
Why?
|
| Curriculum | 1 | 2021 | 616 | 0.030 |
Why?
|
| Sex Factors | 1 | 2020 | 1130 | 0.030 |
Why?
|
| Patient Selection | 1 | 2020 | 708 | 0.030 |
Why?
|
| Vascular Surgical Procedures | 1 | 2017 | 152 | 0.030 |
Why?
|
| Heart Injuries | 1 | 2016 | 24 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 631 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 1996 | 146 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2019 | 983 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 1996 | 136 | 0.030 |
Why?
|
| Thromboxane B2 | 1 | 1995 | 11 | 0.030 |
Why?
|
| Raffinose | 1 | 1995 | 24 | 0.030 |
Why?
|
| Partial Pressure | 1 | 1995 | 51 | 0.030 |
Why?
|
| Indomethacin | 1 | 1995 | 62 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 1819 | 0.030 |
Why?
|
| Reperfusion | 1 | 1995 | 31 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 880 | 0.030 |
Why?
|
| Allopurinol | 1 | 1995 | 77 | 0.030 |
Why?
|
| Vascular Resistance | 1 | 1995 | 104 | 0.030 |
Why?
|
| Glutathione | 1 | 1995 | 107 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2015 | 107 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2017 | 237 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2016 | 355 | 0.030 |
Why?
|
| Stomach | 1 | 2015 | 116 | 0.030 |
Why?
|
| Rabbits | 1 | 1995 | 639 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 514 | 0.030 |
Why?
|
| Observer Variation | 1 | 2015 | 626 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 935 | 0.020 |
Why?
|
| Adenosine | 1 | 1995 | 278 | 0.020 |
Why?
|
| Radiography | 1 | 2013 | 823 | 0.020 |
Why?
|
| Blood Pressure | 1 | 1995 | 926 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2013 | 419 | 0.020 |
Why?
|
| Oxygen | 1 | 1995 | 781 | 0.020 |
Why?
|
| Insulin | 1 | 1995 | 1191 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 1996 | 83 | 0.010 |
Why?
|
| Carotid Stenosis | 1 | 1996 | 115 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 1996 | 1018 | 0.010 |
Why?
|